How to Build Bone Density After 40: Resistance Training, HRT, and Creatine

Stacy Sims relayed a case study of three women in their late 60s, one with osteoporosis, the others osteopenic. They were hesitant about hormone therapy and felt doomed. She put them on a structured program: first bodyweight work to build confidence and base strength, then progressively overloaded heavy lifting (squats, deadlifts, etc.), and finally plyometrics like jumping. The women were initially incredulous, but over 6–8 months all three achieved normal‑range bone density as measured by DEXA, without any fractures. Sims stresses that the old advice to avoid heavy loads and jumping with weak bones is wrong; instead, a gradual, supervised progression is safe and effective. She underscores that bone responds to mechanical strain irrespective of hormone status, and that it’s never too late to start building bone.

Stacy Sims is emphatic that creatine monohydrate is a foundational supplement, not just for men. She explained that the traditional bodybuilding dosing (5 g 4×/day with carbs) caused bloating and was only for performance, but a low daily dose of 3–5 g saturates tissues over ~3 weeks and yields far‑reaching benefits: better muscle power, improved brain metabolism, and support for bone via increased mechanical loading from stronger muscles. The new research on brain health shows that during sleep deprivation or circadian disruption, the brain struggles to clear tau plaques, leading to brain fog. A higher acute dose of 0.38 g/kg (about 20 g for a 60 kg woman) can enhance that cleansing process, helping restore cognitive clarity. She noted that while creatine is not a bone‑density drug, when combined with heavy lifting it helps build the muscle mass that drives bone adaptation.

Stacy Sims frames gut microbiome health as the single most important lever for health span and bone strength. She explains that the menopause transition brings a sharp decline in gut microbial diversity because estrogen’s second‑pass effect through the liver and gut is lost; less estrogen exposure to gut bacteria gives rise to obesogenic bacterial strains that predispose to fat gain and muscle loss. This shift reduces spontaneous activity, further detracting from bone loading. By deliberately eating at least 30 different plant foods each week, women can foster a robust, anti‑inflammatory microbiome. Jocelyn Whitstein adds the specific mechanism: fiber fermentation yields short‑chain fatty acids (SCFAs) that inhibit pathways of bone resorption and joint inflammation, citing data linking a higher dietary inflammatory index to increased fracture risk. The dual emphasis is on moving away from macronutrient counting toward a food‑quality, microbiome‑first approach.

Both experts agree that MHT is a legitimate tool, but they caution against the current pendulum swing. Stacy, who worked on the Women’s Health Initiative, notes that after WHI scared women away, today there’s overcorrection where some believe MHT will restore their 20‑year‑old bone and body. In reality, it slows the rate of bone loss; it does not stop it or build bone like exercise can. Jocelyn points to the Lift More trial: high‑intensity resistance training plus impact yielded a 3% increase in lumbar spine BMD over 8 months, comparable to gains seen with Premarin in the WHI. Thus, for women with menopausal symptoms and low bone density, MHT can be beneficial, but must be coupled with strength and impact training. They emphasize that if a woman cannot use MHT, exercise and diet can deliver similar bone benefits, so no one should feel hopeless.

Jocelyn Whitstein explicitly states that the scale of improvement with combined resistance and impact training is nearly on par with menopausal hormone therapy. She points to the Lift More trial where women gained 3% bone density in the lumbar spine over 8 months, and compares it to the Women’s Health Initiative data where Premarin gave similar lumbo-spine improvement. This reframes exercise not as a mere adjunct but as a legitimate, sometimes equivalent, intervention. Stacy Sims reinforces that MHT only slows loss, while exercise can actually build bone. This is a powerful message for women who cannot or do not want to use HRT.

Jocelyn Whitstein explains that the mechanism of GLP‑1 agonism includes anti‑inflammatory pathways that can protect joints and bone, leading to reduced fracture risk in diabetic populations using lower doses. However, when used solely for weight loss at high doses without the muscle‑maintaining stimulus of resistance training, rapid weight loss includes significant muscle and bone loss, undermining bone density. So the outcome depends on context: combined with protein intake and strength training, the net effect could be neutral or even beneficial. This counters the simplistic narrative that these drugs inevitably harm bone health.

Stacy Sims is frustrated by marketing that touts collagen as a muscle‑building protein; it is structural, not dietary, and only certain types (type II) may help joints. She highlights that individual responsiveness varies, making blanket recommendations difficult. Jocelyn Whitstein adds nuance: type I collagen has some evidence for bone density improvement, but again, not everyone responds. For joint pain, hydrolyzed type II and undenatured type II collagen show some promise, but she advises patients to test individually and be wary of cost‑for‑benefit. Both experts converge on a food‑first, cautious approach: don’t assume collagen is a necessary part of a bone‑health regimen.

Stacy Sims, who worked on the Women’s Health Initiative, notes that the pendulum has swung from fear to over‑enthusiasm. She hears women say “I’m on MHT, so I’m fine with my bones,” but she counters that it only slows the rate of change, it does not stop it, and all the lifestyle pieces — resistance training, impact, proper nutrition — are still required. This correction is critical to prevent women from relying on a prescription as a sole strategy.